Journal · Nephrology · Updated 15 November 2026
Nature Reviews Nephrology
Read Nature Reviews Nephrology reviews on DeepDyve. No university library needed.
Nature Reviews Nephrology is a review journal on kidney disease published by Springer Nature (Nature Portfolio), under its current title since 2009. Its reviews and commentaries cover topics such as inherited kidney diseases, acute kidney injury, chronic kidney disease, inflammation and emerging treatments. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Nature Reviews Nephrology at a glance
- Full title
- Nature Reviews Nephrology
- Abbreviation (NLM)
- Nat Rev Nephrol
- Publisher
- Springer Nature (Nature Portfolio)
- Print ISSN
- 1759-5061
- Online ISSN (eISSN)
- 1759-507X
- Current title since
- 2009
- Subjects
- Nephrology
- Access model
- Subscription
- On DeepDyve
- Research articles; availability varies by article
Ways to access Nature Reviews Nephrology
Nature Reviews Nephrology is a subscription journal. To read its articles, look for a preprint or the authors’ manuscript, check a library, or read them on DeepDyve.
- Preprints. Nature Reviews Nephrology encourages authors to post preprints of their research on servers such as arXiv or bioRxiv. A preprint can differ from the published paper.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Nature Reviews Nephrology. Check its journal list and whether it offers remote access.
- DeepDyve. Read Nature Reviews Nephrology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; Nature Portfolio preprint policy; NIH Public Access Policy.
Impact factor and metrics
Nature Reviews Nephrology’s 2025 Journal Impact Factor is 46.7, and its 5-year Impact Factor is 51.0.
46.7
Journal Impact Factor (2025)
51.0
5-year Impact Factor (2025)
10.732
SCImago Journal Rank (2025)
16 days
Median time to first editorial decision
156 days
Median time from submission to acceptance
Source: Springer Nature journal metrics for Nature Reviews Nephrology. Impact Factor from Clarivate Journal Citation Reports.
Recent Nature Reviews Nephrology research worth reading
Published April to September 2026. Summaries describe what the authors report.
-
Future needs for clinical trials in autosomal dominant polycystic kidney disease
Noting that autosomal dominant polycystic kidney disease is the most common inherited cause of kidney failure and that treatments remain limited, the authors argue that the randomized clinical trials conducted to date offer insights that should guide the development of future trials.
Nature Reviews Nephrology, June 2026 · DOI 10.1038/s41581-026-01070-4
-
‘Missing’ disease-causing variants in Alport syndrome
This review covers why up to 20% of people with clinically suspected Alport syndrome have no disease-causing variant identified by genetic testing, including variants of uncertain significance, phenocopies such as IgA nephropathy and hard-to-detect splicing variants, and how these cases can be resolved.
Nature Reviews Nephrology, July 2026 · DOI 10.1038/s41581-026-01061-5
-
Therapeutic and mechanistic insights on mitochondrial transplantation in kidney disease
This review covers mitochondrial transplantation, the delivery of viable mitochondria to injured tissue, as a treatment approach in kidney disease, and the authors describe preclinical studies in models of ischaemia showing improved kidney function, reduced inflammation and preserved mitochondrial structure.
McCully et al. · Nature Reviews Nephrology, published online April 14, 2026 · DOI 10.1038/s41581-026-01072-2
-
Nucleic acid sensing pathways in kidney disease development
This review covers how mislocalized self nucleic acids, such as mitochondrial DNA, activate sensors including cGAS, STING, AIM2 and Toll-like receptors in the kidney, driving inflammation, cell death and fibrosis in acute kidney injury and chronic kidney disease, and evaluates the therapeutic landscape.
Andrade-Silva et al. · Nature Reviews Nephrology, published online September 1, 2026 · DOI 10.1038/s41581-026-01120-x
-
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes
This review covers inflammation as a treatment target in chronic kidney disease and its cardiovascular complications, including investigational drugs such as selonsertib, baricitinib and antibodies against IL-1β and IL-6, and the anti-inflammatory properties of proven therapies such as SGLT2 inhibitors.
Nature Reviews Nephrology, September 2026 · DOI 10.1038/s41581-026-01117-6
Related journals
Questions about Nature Reviews Nephrology
How can I read Nature Reviews Nephrology articles without a subscription?
For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central. Your library may also subscribe. DeepDyve lets you read Nature Reviews Nephrology articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Nature Reviews Nephrology?
Nature Reviews Nephrology’s NLM (PubMed) abbreviation is Nat Rev Nephrol.
What is the ISSN of Nature Reviews Nephrology?
The print ISSN is 1759-5061 and the online ISSN is 1759-507X.
Is Nature Reviews Nephrology open access?
Nature Reviews Nephrology articles are published under the subscription model; none of the 109 articles it published from January 1 to November 14, 2026 carry a Creative Commons license in Crossref.
What is the impact factor of Nature Reviews Nephrology?
Nature Reviews Nephrology’s Journal Impact Factor is 46.7 (2025), and its 5-year Impact Factor is 51.0, according to Springer Nature’s published metrics.
Nature Reviews Nephrology articles on DeepDyve are licensed from Springer Nature. Journal facts as of 15 November 2026.
Start reading Nature Reviews Nephrology today
One month free, then less than $2 a day. Nature Reviews Nephrology, plus millions of articles from thousands of journals.




